Investorideas.com - Cannabis Deal Tracker: Investment and M&A Activity in the Cannabis Industry September 21st - September 25th, 2020
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Wednesday, 30 September 2020
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 474 (TSX: $VLNS.TO) (OTCQX: $VLNCF) (TSXV: $NDVA.V) (OTCQX: $NDVAF)
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 474 (TSX: $VLNS.TO) (OTCQX: $VLNCF) (TSXV: $NDVA.V) (OTCQX: $NDVAF)
Today’s podcast
sponsored by Cannabis Suisse Corp. (OTC: $CSUI), a fully licensed cannabis
cultivation and distribution company in Switzerland
Delta, Kelowna, BC, September 30, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2020/093020-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/09302CSUI-VLNS-VLNCF-NDVA-NDVAF.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
Today’s podcast is
sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully
licensed cannabis cultivation and distribution company in Switzerland, for
recreational tobacco products and medical CBD oils. The Company's facilities
for producing cannabis are based in Dietikon, Switzerland, and contain the art
surveillance equipment to enable an around the clock webcast. Cannabis Suisse
grows high quality, organic cannabis with sustainable, all-natural principles.
The Company's products are laboratory tested to ensure the end users have
access to a standardized, safe and consistent product. Cannabis Suisse
proprietary trademarked MoldStandard is a quantitative microbiology method for
analyzing yeast and mold counts in harvested cannabis plants. Cannabis Suisse
proprietary trademarked CannaMec is a method for quantifying and removing
residual solvents during packaging and storage of CBD products. Cannabis Suisse
Corp. currently sells via a distribution network of Swiss retailers and online shops,
under the retail brand Alpine Cannabis.
In
today’s podcast we look at a few public and private company announcements.
Hyasynth, a sustainable
biotechnology company, announced taking
the top spot from global competitors by making the first ever sale of
cannabidiol (CBD) produced and extracted from yeast. Hyasynth produces CBD
through a yeast fermentation process, without the need for traditional
cultivation and extraction from cannabis or hemp plants. The material was
produced using Hyasynth's proprietary yeast under contract by a fermentation
partner. This production marks a key commercialization achievement and
positions the company to move towards large scale commercial manufacturing.
Hyasynth
was among the first companies to specialize in cannabinoid production by
fermentation, also called cellular agriculture or biosynthesis - a field that
has seen more than $500 million in investments over the last three years.
Cannabinoids that are produced this way are expected to provide huge benefits
in cost, quality and sustainability versus traditional plant cultivation and
extraction. Hyasynth's platform allows it to produce CBD, one of only two
natural cannabinoids in clinically proven products. The company's primary
competitors have recently announced work on CBG, the precursor to CBD, which is
easier to make but lacks an established market.
Hyasynth's
fermentation process takes less than one week to complete, making it 12 times
faster than production by cannabis or hemp plants. Fermentation is a
traditional manufacturing process for pharmaceutical, food and cosmetic
products. A widely known example of this process is the production of insulin
by bacteria. Unlike other production methods, fermentation results in natural,
bio-based products and final ingredients that are pesticide and GMO-free.
Hyasynth's technology can be scaled through partnerships with fermentation
facilities that already exist worldwide. With these product features, Hyasynth
is set to reshape the industry for major cannabinoids, like THC and CBD, and
rare cannabinoids that are found in very low levels in cannabis and hemp
plants.
While an
increasing number of medical researchers and consumers are finding benefits
from CBD, many CBD suppliers and products have recently been warned by
regulatory agencies for listing false information on the quantity of CBD and
type of ingredients in their products. Hyasynth's technology provides a
reliable option for the global supply chain.
"Our
head start in this area was a key factor in us being the first to reach
commercial sale of CBD and CBDa produced from a reliable and sustainable
source." said Kevin Chen, CEO of Hyasynth. "We've assembled an
excellent team of researchers, built an IP portfolio across many cannabinoids,
and our production & sale achievement is one of the last checkpoints before
we make our solution available worldwide." The company is in the process
of scaling up its CBD and CBDa production process to industrial volumes and
aims to deliver scaled production in 2021.
The
Valens Company Inc. (TSX:
VLNS) (OTCQX:
VLNCF) announced the
launch of a new higher potency cannabis-infused beverage, Summit 10, under a
white label agreement with A1 Cannabis Company (a subsidiary of Iconic
Brewing).
Summit 10, a lemonade iced tea
containing 10mg of THC, is the third addition to The Valens Company and A1's
line of cannabis-infused beverages. Available in a 355ml bottle, Summit 10
differentiates from the previously released 2.5mg THC-infused Summit beverage,
with a flavour profile of citrus and black tea and a higher potency level. Summit 10 was developed using SōRSE by Valens
emulsion technology and is designed for consumers seeking a higher dosage
product with faster observed onset times and reduced offset times, housed in a
resealable bottle for convenient and controlled consumption.
Earlier this year, The Valens
Company introduced its first line of cannabis infused beverages in partnership
with A1 Cannabis – Basecamp, a CBD-forward iced tea, and Summit, a THC-forward
citrus-flavoured water. Both have quickly gained popularity in the Canadian
cannabis-infused beverage market, receiving acclaim for their differentiated
taste and customizable dosing from the industry and consumers alike.
"As an anticipated addition to
A1's cannabis-infused beverage line, we bring Summit 10 to the Canadian market,
a reimagined THC-forward formulation with more potency and differentiated
taste, but with the same quality consumers have come to favour in Summit,"
said Tyler Robson, Chief Executive Officer of The Valens Company. "As the
Canadian cannabis-infused beverage market matures, it is our commitment to
continue to innovate and differentiate for our partners using SōRSE by Valens,
but also reinvent trusted products that offer customizable experiences in
various potency levels and taste profiles to meet a wide range of consumer
preferences. We are thrilled to launch Summit 10 as part of our continued
collaboration with A1 Cannabis to introduce new products and increase our
collective market share in the rapidly growing beverage segment in
Canada."
Summit 10 is expected to first
launch in mid-October in Alberta online and at select retailers, with British
Columbia and Ontario to follow shortly after. The Valens Company and A1
Cannabis also expect to release a zero sugar Summit 10 beverage this fall.
Indiva
Limited (TSXV:NDVA) (OTCQX:NDVAF), the
parent company of Indiva Inc., a leading Canadian producer of cannabis edibles
and other cannabis products, announced that
the first three flavours of Wana™ Sour Gummies have shipped to Alberta,
Saskatchewan, and Yukon Territory. Mango
Sativa (5 mg THC per gummie),
Watermelon Hybrid (5 mg THC per gummie),
and Strawberry Lemonade 1:1 (5 mg THC, 5 mg CBD per gummie) are expected to
be in stores this week.
“We’re thrilled to have shipped
Wana™ Sour Gummies to Alberta, Saskatchewan, and Yukon Territory, increasing
Wana™’s presence to four provinces and one territory,” said Niel Marotta,
President and Chief Executive Officer of Indiva. “In less than a month since
Wana™ Sour Gummies were launched, we’ve seen a steady growth in popularity for
these vegan and gluten-free cannabis edibles. Of-age Canadians across the
country are experiencing first-hand why Wana™ Brands is the No. 1 edibles brand
in the United States.”
Wana™ Sour Gummies are made with
pectin, not gelatin, which gives the gummies a great texture in addition to
making them vegan. All gummies are handcrafted using a shelf-stable recipe so
they won’t melt. Following the first three flavours that have been released,
the Company intends to bring these additional flavours to market later in 2020:
●
Blueberry Indica (5 mg THC per gummie)
●
Strawberry 10:1 (10 mg CBD, 1 mg THC per
gummie)
●
Japanese Citrus Yuzu 2:1 (10 mg CBD, 5 mg
THC per gummie)
●
Pomegranate Blueberry Acai 5:1 (25 mg CBD,
5 mg THC per gummie)
Wana™ Brands is the No. 1 edibles
brand in the United States, with more dollars sold than any other brand,
according to BDSA 2019 Brand Share Report.
ANC
Inc,
Alberta's first licensed micro cultivator, announced the
continuation of their national expansion with approval to supply seeds for the
commercial and home grower in British Columbia, Alberta, Saskatchewan, Ontario
and most recently, New Brunswick.
"Since 2017, ANC Cannabis has
been forming a company built around the belief that we can create quality
product that is accessible to everyone while also providing educational support
and services to our consumers," said Tairance Rutter, ANC Inc.'s VP
Business Development and Marketing. Adding, "At ANC we are motivated by a
passion for quality product and support for the entire growing and cultivation
community. We believe that everyone, no matter their background or experience,
should be able to grow their own quality cannabis plants."
ANC is first and foremost a genetics
company committed to developing the highest quality products possible. ANC is
currently focused on seeds for the consumer and commercial market, with plans
to release flower for retail sale in the late fall of 2020. The company has
been approved for a processing licence so they can process their own product.
The company has additional long-term plans to sell flower, likely in the form
of pre-rolls sourced from the genetics they will be offering consumers as seed
stock. This approach will allow consumers to experience the product before
deciding on a cultivar. This will be part of a larger program the company calls
the "Know Before You Grow" service, which will also include access to
an online platform offering genetics-specific tips for home growers. ANC Inc's VP of Research and Quality Control,
Thomas Facciolo, is excited to provide answers for all our home growers'
questions.
"ANC continues to expand at a
rapid pace, and we are elated to have reached the milestone of national
distribution, spanning across Canada, from the West Coast in British Columbia
to the East Coast in New Brunswick," said ANC Inc President, Clayton
Bordeniuk. Adding, "this is just the beginning for ANC."
ANC has developed hundreds of
different genetics that are ready for the recreational market including Fruity
Hoops, Pink Lemonade, Pineapple Express, Power Kush, Triple Scoop, Bubba Kush
2.5, Chocolate Cake, Double Chocolate, 34 ST Cookies, Bubba Cheese and Sorbet
33. Each strain offers a different genetic make up, with a wide range of THC
concentration, and different flowering periods, appropriate for a variety of
climates for indoor and outdoor growers alike.
Once again, today’s podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investors can trade these stocks and other ideas on our site using our list
of top stock trading apps including Robinhood , Acorn, Stash and others.
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy:
https://www.investorideas.com/About/Private_Policy.asp
Disclosure: Cannabis
Suisse Corp. (OTC: CSUI ),is
a paid featured company on Investorideas.com Investor Ideas does
not condone the use of cannabis except where permissible by law. Our site does
not possess, distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
Investor Ideas #Potcasts Episode 473- #Cannabis News and #Stocks on the Move; Interview with Cannabis Suisse Corp. (OTC: $CSUI) COO and President @SuisseCorp
Investor Ideas #Potcasts Episode 473- #Cannabis News and #Stocks on the Move; Interview with Cannabis Suisse Corp. (OTC: $CSUI) COO and President @SuisseCorp
Alain
Parrik discusses company’s operations during COVID-19, new
product development plans and upcoming launch of a new brand on Amazon
Delta, Kelowna, BC, September 30, 2020 - Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
In today’s podcast Investor Ideas interviews Alain Parrik, COO and President of Cannabis Suisse Corp. (OTC: CSUI), where we discuss the company’s operations during COVID-19, new product development plans, as well as their recent announcement regarding their online expansion plans including the upcoming launch of a new brand on Amazon.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2020/092920-StocksToWatch.mp3
Read this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/09301Interview-CSUI.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Сannabis
Suisse Corp. is developing its own line of products including hemp oil, hemp
protein, hemp gummies and hemp hearts with all the appropriate certificates and
licenses for sale on Amazon.
This
news follows a recent announcement for online distribution of its cannabis and
CBD products with uWeed from their retail outlets and online store (www.uweed.ch).
The
expansion into online sales of hemp gives the company, headquartered in
Switzerland, wider access and inroads into the US markets and legal environment
for CBD products as it evolves.
Mr.
Alain Parrik, COO & Director said, "Amazon is an important
distribution outlet for us as we ramp up for expansion across multiple online
retail platforms. Introducing a new line of hemp products paves the wave for
additional products in the future."
Cannabis
Suisse Corp. will be in compliance with Amazon rules and respects their
position that CBD is currently banned on Amazon but hemp products are not.
The
Company, as a registered manufacturer of both products will continue to use
flowers with the highest concentration of CBD. For the new Amazon product line,
oil will be squeezed from the seeds allowing Cannabis Suisse to use the whole
plant in its production and benefit from it.
When
asked about the last few months of business through COVID-19 leading up to
their recent announcement of adding hemp based products to Amazon, Patrick
commented, “The coronavirus pandemic and the quarantine imposed because of it
have changed the habits of people around the world. People work, shop and plan
differently. At first, the coronavirus seemed disruptive to business, but the
demand for cannabis during quarantine is greater than ever before. Sales in the
US were up 159% by mid-March, according to Headset. Sales of beverages with
added cannabis increased by 14% and sales of edible products increased by 28%.
The report also says that because the virus infects the respiratory systems,
consumers choose to eat or drink cannabis rather than just smoke it.”
Parrick
continued, saying, “The recent outbreak of the coronavirus disease did not
affect the company’s operations. In fact, due to worrying about the health, and
being forced to stay at home people started becoming more curious of the
positive effects of CBD. This has lead to increase in demand of the CSUI
products in Europe which is surely affecting the operations in a good way. Our
Company was able to show its potential in quarantine Covid-19. Under the retail
brand, Alpine Cannabis, new product lines have been released.”
When
asked to discuss in more detail their recent deal with Amazon, Parrick
commented, “Amazon is a US company, the largest in the world among online
market platforms. Currently it covers 34 product categories and supports
individual retail sites for some countries. The platform offers international
shipping for some goods as well. The number of platform users is constantly
increasing, the company's capitalization is growing accordingly.
Cannabis Suisse Corp. believes such
a solution is strategically beneficial to increase its revenue and brand
awareness. Being a company headquartered in Switzerland, Cannabis Suisse Corp.
gains even wider access to the US market, thus the implementation of this
intention will have a significant effect on both the growth of the Company and
the growth of income of its shareholders. It will also simplify the access of
average consumers to the product. Realizing the quality of the product and
feeling it on themselves, customers will build a trusting and long-term
relationship with the Company, which may affect their desire to become a
shareholder of Cannabis Suisse Corp. The Company, as a registered manufacturer
of both products will continue to use flowers with the highest concentration of
CBD. But for the new Amazon product line, oil will be squeezed from the seeds.
In this way, Cannabis Suisse Corp. will be able to use the whole plant in its
production and benefit from it.”
When
asked about the EU CBD and cannabis space right now, (more specifically
Switzerland) Alain went on to discuss some of the many benefits as well as the
larger issues facing the market so far and how CSUI has stood out in said
market.
“The Swiss market has a few big
competitors now, the rest are small farms with under 1,000 plants in production
and mostly outdoor. The big farms have more than 20,000 plants as indoor
growing and from 10 to 50 Acers of outdoor growing. During the indoor growing,
it is very difficult to get the harvest in good quality so a lot of small farms
were closed again in 2018 as it is not possible to make a profit with farms of
1000-3000 plants. We have growers with many years’ experience for indoor grow
and our result demonstrates it clearly, we make about 20-gram high-quality
flowers heads per plant over an 8-week period. Our progress during this year is
not remarkable, but there are some results we have already achieved. In January
2019 we got Grow Factory with facility for 1,700 plants, our possessions have
expanded to two more rooms with 2,000 plants and we were running 3,700 plants
in total. We have been expanding further since summer 2019 and have more than
5,000 plants now.
The biggest issue in Switzerland is
to find a landlord for indoor grow who accepts CBD production. But our
situation is unique, and we managed to rent the territory of 556.5 m2 and get
approval for our 4000 m2 place which is planned to be available on December 1,
2020.
The prices on weed have been dumbing
in Switzerland, so in order to get a part of the market we have to reduce the
price and produce more weed. For the EU market we will make an additional
product line with dietary supplements, cosmetic, soft drinks etc.
In 2021 we will organize our working
process involving first outdoor field to make 16,000 kg of raw material for our
oil production.”
When
asked what investors should be looking for from CSUI as well as how the Swiss
and EU cannabis space might change over the next year, Parrick commented,
“There are coming big changes in the EU regulative connected with cannabis
nowadays, but in some countries the healthcare department treats CBD only as a
medical product and will not allow it as Diet Supplements or Food Supplies. So
people can only buy CBD on the internet under their own responsibility.
However, we managed to launch the import of CBD-vape oil and Sativa hemp flowers
to EU as B2B and direct shops sales. Cannabis Suisse Corp. has forward-looking
plans to expand outside Switzerland developing customized products. Some
European countries like Germany, Denmark, Malta, Greece, and Italy discussed
the possibility of creating a completely regulated cannabis market by 2028.
Furthermore, Luxembourg intends to introduce a regulated market for adult use
of cannabis by 2023.
Based on all of the above advantages
of the Company’s products, the situation in the European market and forthcoming
amendments to the legislation, the Company’s decision to launch new product
lines and enter the EU market is more than an appropriate and timely one.”
Investors
can trade these stocks and other ideas on our site using our list
of top stock trading apps including Robinhood, Acorn, Stash
and others.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. Disclosure: Cannabis
Suisse Corp. (OTC: CSUI), is
a paid featured company on Investorideas.com More
disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow
us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor Ideas - news,
articles, podcasts and stock directories
Buy a cannabis guest post on
Investorideas.com
Subscribe to:
Posts (Atom)
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ... -
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: Dixie Brands (CSE: $DIXI_U.C) (OTC: $DXBRF), Khiron Life Sciences (T... -
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...